The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue The Journal of Allergy and Clinical Immunology: In Practice Année : 2021

The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective

Marek Jutel
Ioana Agache
Wienczyslawa Czarlewski
Alvaro Cruz
Vincenzo Patella
Mohamed Shamji

Résumé

Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic rhinitis and/or asthma. Many international or national practice guidelines have been produced, but the evidence-based method varies and they do not usually propose care pathways. The present article considers the possible role of mobile health in AIT for allergic rhinitis/asthma. There are no currently available validated biologic biomarkers that can predict AIT success, and mobile health biomarkers have some relevance. In the current article, the following aspects will be discussed: patient stratification for AIT, symptom-medication scores for the follow-up of patients, clinical trials, as well as the approach of the European Academy of Allergy and Clinical Immunology.
Fichier principal
Vignette du fichier
S2213219821002403.pdf (265.27 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03672676 , version 1 (09-05-2023)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Jean Bousquet, Marek Jutel, Oliver Pfaar, Joao Fonseca, Ioana Agache, et al.. The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective. The Journal of Allergy and Clinical Immunology: In Practice, 2021, 9 (5), pp.1805-1812. ⟨10.1016/j.jaip.2021.02.035⟩. ⟨hal-03672676⟩
18 Consultations
20 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More